{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:06:19Z","timestamp":1789200379044,"version":"build-2803163510"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005639","name":"Universidade De S\u00e3o Paulo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005639","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Indoleamine 2,3-dioxygenase 1 (IDO1) is an intracellular heme-dependent enzyme that catalyzes the initial oxidation of L-tryptophan into the kynurenine pathway, thereby linking tryptophan metabolism to immune regulation. IDO1 expression is mainly induced by interferon-\u03b3 during immune activation and inflammation, and its activity helps control immune responses through tryptophan depletion and the generation of immunomodulatory metabolites. Because of its central role in immunometabolism, IDO1 has been widely investigated as a therapeutic target, and several strategies have been developed to inhibit its enzymatic activity or reduce its functional contribution to immune suppression. However, increasing evidence indicates that IDO1 inhibition may not completely interrupt tryptophan catabolism or downstream immunoregulatory signaling. Instead, IDO1 blockade can be accompanied by compensatory mechanisms that preserve metabolic and immune regulatory outputs. These mechanisms may include activity or upregulation of alternative tryptophan-catabolizing enzymes such as TDO2, IDO2, and IL4I1; metabolic diversion toward serotonin and melatonin pathways; microbiota-derived indole production; and cell-type-specific metabolic rewiring. Therefore, understanding these adaptive responses is essential for interpreting the limited efficacy of IDO1-targeted approaches and for improving therapeutic strategies directed at tryptophan metabolism. This review discusses the main compensatory pathways that may emerge under IDO1 inhibition and their relevance to developing more effective immunometabolic interventions.<\/jats:p>","DOI":"10.1007\/s11033-026-12707-9","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T07:33:17Z","timestamp":1789198397000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Compensatory pathways in tryptophan metabolism and immune regulation following IDO inhibition"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6637-772X","authenticated-orcid":false,"given":"Isabela","family":"Gontijo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5537-1526","authenticated-orcid":false,"given":"Mariana","family":"Camur\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1284-4038","authenticated-orcid":false,"given":"Jos\u00e9 Roberto","family":"Kfoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,12]]},"reference":[{"issue":"1","key":"12707_CR1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/bjc.2011.513","volume":"106","author":"L Ferdinande","year":"2012","unstructured":"Ferdinande L, Decaestecker C, Verset L et al (2012) Clinicopathological significance of indoleamine 2,3-dioxygenase 1 expression in colorectal cancer. Br J Cancer 106(1):141\u2013147. https:\/\/doi.org\/10.1038\/bjc.2011.513","journal-title":"Br J Cancer"},{"issue":"9","key":"12707_CR2","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1007\/s00726-014-1766-3","volume":"46","author":"G Pantouris","year":"2014","unstructured":"Pantouris G, Serys M, Yuasa HJ, Ball HJ, Mowat CG (2014) Human indoleamine 2,3-dioxygenase-2 has substrate specificity and inhibition characteristics distinct from those of indoleamine 2,3-dioxygenase-1. Amino Acids 46(9):2155\u20132163. https:\/\/doi.org\/10.1007\/s00726-014-1766-3","journal-title":"Amino Acids"},{"issue":"2","key":"12707_CR3","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.bbamem.2014.10.021","volume":"1848","author":"YD Bhutia","year":"2015","unstructured":"Bhutia YD, Babu E, Ganapathy V (2015) Interferon-\u03b3 induces a tryptophan-selective amino acid transporter in human colonic epithelial cells and mouse dendritic cells. Biochim Biophys Acta 1848(2):453\u2013462. https:\/\/doi.org\/10.1016\/j.bbamem.2014.10.021","journal-title":"Biochim Biophys Acta"},{"key":"12707_CR4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.placenta.2021.09.008","volume":"115","author":"GG Murthy","year":"2021","unstructured":"Murthy GG, Prideaux MA, Armstrong M et al (2021) Characterization of the temporal, cell-specific and interferon-inducible patterns of indoleamine 2,3 dioxygenase 1 (IDO1) expression in the human placenta across gestation. Placenta 115:129\u2013138. https:\/\/doi.org\/10.1016\/j.placenta.2021.09.008","journal-title":"Placenta"},{"key":"12707_CR5","doi-asserted-by":"publisher","first-page":"176420","DOI":"10.1016\/j.ejphar.2024.176420","volume":"968","author":"M Gon\u00e7alves","year":"2024","unstructured":"Gon\u00e7alves M, Furgiuele A, Rasini E et al (2024) A peripheral blood mononuclear cell-based in vitro model: A tool to explore indoleamine 2, 3-dioxygenase-1 (IDO1). Eur J Pharmacol 968:176420. https:\/\/doi.org\/10.1016\/j.ejphar.2024.176420","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"12707_CR6","doi-asserted-by":"publisher","first-page":"870","DOI":"10.3390\/pharmaceutics16070870","volume":"16","author":"Z Xing","year":"2024","unstructured":"Xing Z, Li X, He ZNT et al (2024) IDO1 Inhibitor RY103 Suppresses Trp-GCN2-Mediated Angiogenesis and Counters Immunosuppression in Glioblastoma. Pharmaceutics 16(7):870. https:\/\/doi.org\/10.3390\/pharmaceutics16070870","journal-title":"Pharmaceutics"},{"issue":"636","key":"12707_CR7","doi-asserted-by":"publisher","first-page":"eabg8402","DOI":"10.1126\/scitranslmed.abg8402","volume":"14","author":"K Odunsi","year":"2022","unstructured":"Odunsi K, Qian F, Lugade AA et al (2022) Metabolic adaptation of ovarian tumors in patients treated with an IDO1 inhibitor constrains antitumor immune responses. Sci Transl Med 14(636):eabg8402. https:\/\/doi.org\/10.1126\/scitranslmed.abg8402","journal-title":"Sci Transl Med"},{"issue":"5","key":"12707_CR8","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.molcel.2022.02.007","volume":"82","author":"A Fiore","year":"2022","unstructured":"Fiore A, Zeitler L, Russier M et al (2022) Kynurenine importation by SLC7A11 propagates anti-ferroptotic signaling. Mol Cell 82(5):920\u2013932e7. https:\/\/doi.org\/10.1016\/j.molcel.2022.02.007","journal-title":"Mol Cell"},{"issue":"10","key":"12707_CR9","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1021\/acsptsci.4c00265","volume":"7","author":"E Panfili","year":"2024","unstructured":"Panfili E, Rezzi SJ, Adamo A et al (2024) Identification of a Compound Inhibiting Both the Enzymatic and Nonenzymatic Functions of Indoleamine 2,3-Dioxygenase 1. ACS Pharmacol Transl Sci 7(10):3056\u20133070. https:\/\/doi.org\/10.1021\/acsptsci.4c00265","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"Suppl 1","key":"12707_CR10","doi-asserted-by":"publisher","first-page":"A72","DOI":"10.1186\/1710-1492-10-S1-A72","volume":"10","author":"Y Zhu","year":"2014","unstructured":"Zhu Y, Thiele J, Ellis AK (2014) Analysis of indoleamine 2,3-dioxygenase 1 (IDO1) expression of cultured cord blood adherent mononuclear cells as an indicator of atopic risk. Allergy Asthma Clin Immunol 10(Suppl 1):A72. https:\/\/doi.org\/10.1186\/1710-1492-10-S1-A72","journal-title":"Allergy Asthma Clin Immunol"},{"key":"12707_CR11","doi-asserted-by":"publisher","unstructured":"Abdelhamid A, Saad E (2026) IFN-\u03b3 orchestrates coordinated immunosuppression in head and neck squamous cell carcinoma through JAK-STAT-IRF8 signaling: a transcriptome-wide computational analysis. bioRxiv 20260326714228. https:\/\/doi.org\/10.64898\/2026.03.26.714228","DOI":"10.64898\/2026.03.26.714228"},{"issue":"5","key":"12707_CR12","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1007\/s00432-020-03390-9","volume":"147","author":"T Iwasaki","year":"2020","unstructured":"Iwasaki T, Kohashi K, Toda Y, Ishihara S, Yamada Y, Oda Y (2020) Association of PD-L1 and IDO1 expression with JAK\u2013STAT pathway activation in soft-tissue leiomyosarcoma. J Cancer Res Clin Oncol 147(5):1451\u20131463. https:\/\/doi.org\/10.1007\/s00432-020-03390-9","journal-title":"J Cancer Res Clin Oncol"},{"issue":"27","key":"12707_CR13","doi-asserted-by":"publisher","first-page":"9238","DOI":"10.1073\/pnas.0802130105","volume":"105","author":"N Wenta","year":"2008","unstructured":"Wenta N, Strauss H, Meyer S, Vinkemeier U (2008) Tyrosine phosphorylation regulates the partitioning of STAT1 between different dimer conformations. Proc Natl Acad Sci U S A 105(27):9238\u20139243. https:\/\/doi.org\/10.1073\/pnas.0802130105","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"12707_CR14","doi-asserted-by":"publisher","first-page":"6767","DOI":"10.4049\/jimmunol.0900331","volume":"183","author":"KE Barnholt","year":"2009","unstructured":"Barnholt KE, Kota RS, Aung HH, Rutledge JC (2009) Adenosine Blocks IFN-\u03b3-Induced Phosphorylation of STAT1 on Serine 727 to Reduce Macrophage Activation. J Immunol 183(10):6767\u20136777. https:\/\/doi.org\/10.4049\/jimmunol.0900331","journal-title":"J Immunol"},{"issue":"1","key":"12707_CR15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jmb.2010.07.013","volume":"402","author":"J Nardozzi","year":"2010","unstructured":"Nardozzi J, Wenta N, Yasuhara N, Vinkemeier U, Cingolani G, Molecular basis for the recognition of phosphorylated STAT1 by importin \u03b15 (2010) J Mol Biol 402(1):83\u2013100. https:\/\/doi.org\/10.1016\/j.jmb.2010.07.013","journal-title":"J Mol Biol"},{"issue":"17","key":"12707_CR16","doi-asserted-by":"publisher","first-page":"8107","DOI":"10.1093\/nar\/gkt589","volume":"41","author":"M Trilling","year":"2013","unstructured":"Trilling M, Bellora N, Rutkowski AJ et al (2013) Deciphering the modulation of gene expression by type I and II interferons combining 4sU-tagging, translational arrest and in silico promoter analysis. Nucleic Acids Res 41(17):8107\u20138125. https:\/\/doi.org\/10.1093\/nar\/gkt589","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"12707_CR17","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1074\/jbc.M116.745448","volume":"292","author":"S Moretti","year":"2017","unstructured":"Moretti S, Menicali E, Nucci N et al (2017) Signal Transducer and Activator of Transcription 1 Plays a Pivotal Role in RET\/PTC3 Oncogene-induced Expression of Indoleamine 2,3-Dioxygenase 1. J Biol Chem 292(5):1785\u20131797. https:\/\/doi.org\/10.1074\/jbc.M116.745448","journal-title":"J Biol Chem"},{"issue":"2","key":"12707_CR18","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/cas.70255","volume":"117","author":"T Ebina","year":"2026","unstructured":"Ebina T, Ri M, Marumo Y et al (2026) Targeting Overexpressed IDO in Stromal Cells as a Potential Therapeutic Strategy in Multiple Myeloma. Cancer Sci 117(2):325\u2013334. https:\/\/doi.org\/10.1111\/cas.70255","journal-title":"Cancer Sci"},{"issue":"40","key":"12707_CR19","doi-asserted-by":"publisher","first-page":"16251","DOI":"10.1021\/ja207066z","volume":"133","author":"J Basran","year":"2011","unstructured":"Basran J, Efimov I, Chauhan N et al (2011) The Mechanism of Formation of N-Formylkynurenine by Heme Dioxygenases. J Am Chem Soc 133(40):16251\u201316257. https:\/\/doi.org\/10.1021\/ja207066z","journal-title":"J Am Chem Soc"},{"key":"12707_CR20","doi-asserted-by":"publisher","first-page":"103957","DOI":"10.1016\/j.redox.2025.103957","volume":"89","author":"D Li","year":"2026","unstructured":"Li D, Zhang Y, Kuang Y et al (2026) Reprogramming of the kynurenine pathway impairs NAD+ homeostasis and mediates doxorubicin-induced cardiotoxicity in mice. Redox Biol 89:103957. https:\/\/doi.org\/10.1016\/j.redox.2025.103957","journal-title":"Redox Biol"},{"issue":"7902","key":"12707_CR21","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/s41586-022-04499-2","volume":"603","author":"A Pataskar","year":"2022","unstructured":"Pataskar A, Champagne J, Nagel R et al (2022) Tryptophan depletion results in tryptophan-to-phenylalanine substitutants. Nature 603(7902):721\u2013727. https:\/\/doi.org\/10.1038\/s41586-022-04499-2","journal-title":"Nature"},{"issue":"17","key":"12707_CR22","doi-asserted-by":"publisher","first-page":"4825","DOI":"10.1038\/s44318-025-00505-1","volume":"44","author":"G Figlia","year":"2025","unstructured":"Figlia G, M\u00fcller S, Garcia-Cortizo F et al (2025) mTORC1 senses glutamine and other amino acids through GCN2. EMBO J 44(17):4825\u20134866. https:\/\/doi.org\/10.1038\/s44318-025-00505-1","journal-title":"EMBO J"},{"issue":"10","key":"12707_CR23","doi-asserted-by":"publisher","first-page":"5953","DOI":"10.4049\/jimmunol.1001628","volume":"185","author":"Y Yan","year":"2010","unstructured":"Yan Y, Zhang GX, Gran B et al (2010) IDO upregulates regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T cell responses in experimental autoimmune encephalomyelitis. J Immunol 185(10):5953\u20135961. https:\/\/doi.org\/10.4049\/jimmunol.1001628","journal-title":"J Immunol"},{"issue":"6","key":"12707_CR24","doi-asserted-by":"publisher","first-page":"e006728","DOI":"10.1136\/jitc-2023-006728","volume":"11","author":"M Solvay","year":"2023","unstructured":"Solvay M, Holfelder P, Klaessens S et al (2023) Tryptophan depletion sensitizes the AHR pathway by increasing AHR expression and GCN2\/LAT1-mediated kynurenine uptake, and potentiates induction of regulatory T lymphocytes. J Immunother Cancer 11(6):e006728. https:\/\/doi.org\/10.1136\/jitc-2023-006728","journal-title":"J Immunother Cancer"},{"issue":"9","key":"12707_CR25","doi-asserted-by":"publisher","first-page":"101717","DOI":"10.1016\/j.xcrm.2024.101717","volume":"5","author":"LL Kenney","year":"2024","unstructured":"Kenney LL, Chiu RSY, Dutra MN et al (2024) mRNA-delivery of IDO1 suppresses T cell-mediated autoimmunity. Cell Rep Med 5(9):101717. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101717","journal-title":"Cell Rep Med"},{"issue":"1","key":"12707_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/osi2.1109","volume":"19","author":"H Anzai","year":"2022","unstructured":"Anzai H, Yoshimoto S, Okamura K, Hiraki A, Hashimoto S (2022) IDO1-mediated Trp-kynurenine-AhR signal activation induces stemness and tumor dormancy in oral squamous cell carcinomas. Oral Sci Int 19(1):31\u201343. https:\/\/doi.org\/10.1002\/osi2.1109","journal-title":"Oral Sci Int"},{"issue":"1","key":"12707_CR27","doi-asserted-by":"publisher","first-page":"19668","DOI":"10.1038\/s41598-023-47066-z","volume":"13","author":"R Haidar","year":"2023","unstructured":"Haidar R, Shabo R, Moeser M, Luch A, Kugler J (2023) The nuclear entry of the aryl hydrocarbon receptor (AHR) relies on the first nuclear localization signal and can be negatively regulated through IMP\u03b1\/\u03b2 specific inhibitors. Sci Rep 13(1):19668. https:\/\/doi.org\/10.1038\/s41598-023-47066-z","journal-title":"Sci Rep"},{"issue":"1","key":"12707_CR28","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1038\/s41467-025-56574-7","volume":"16","author":"X Diao","year":"2025","unstructured":"Diao X, Shang Q, Guo M et al (2025) Structural basis for the ligand-dependent activation of heterodimeric AHR-ARNT complex. Nat Commun 16(1):1282. https:\/\/doi.org\/10.1038\/s41467-025-56574-7","journal-title":"Nat Commun"},{"issue":"1","key":"12707_CR29","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1038\/s41467-020-17750-z","volume":"11","author":"LF Campesato","year":"2020","unstructured":"Campesato LF, Budhu S, Tchaicha J et al (2020) Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine. Nat Commun 11(1):4011. https:\/\/doi.org\/10.1038\/s41467-020-17750-z","journal-title":"Nat Commun"},{"key":"12707_CR30","doi-asserted-by":"publisher","first-page":"107022","DOI":"10.1016\/j.imlet.2025.107022","volume":"275","author":"DMT Bosma","year":"2025","unstructured":"Bosma DMT, Busselaar J, Staal MD et al (2025) CD4\u2009+\u2009T-cell help delivery to monocyte-derived dendritic cells promotes effector differentiation of helper and cytotoxic T cells. Immunol Lett 275:107022. https:\/\/doi.org\/10.1016\/j.imlet.2025.107022","journal-title":"Immunol Lett"},{"issue":"2","key":"12707_CR31","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.canlet.2016.03.052","volume":"376","author":"CC Lee","year":"2016","unstructured":"Lee CC, Yang WH, Li CH, Cheng YW, Tsai CH, Kang JJ (2016) Ligand independent aryl hydrocarbon receptor inhibits lung cancer cell invasion by degradation of Smad4. Cancer Lett 376(2):211\u2013217. https:\/\/doi.org\/10.1016\/j.canlet.2016.03.052","journal-title":"Cancer Lett"},{"issue":"29","key":"12707_CR32","doi-asserted-by":"publisher","first-page":"11342","DOI":"10.1074\/jbc.RA119.008882","volume":"294","author":"UH Jin","year":"2019","unstructured":"32, Jin UH, Karki K, Cheng Y, Michelhaugh SK, Mittal S, Safe S (2019) The aryl hydrocarbon receptor is a tumor suppressor-like gene in glioblastoma. J Biol Chem 294(29):11342\u201311353. https:\/\/doi.org\/10.1074\/jbc.RA119.008882","journal-title":"J Biol Chem"},{"issue":"1","key":"12707_CR33","doi-asserted-by":"publisher","first-page":"111963","DOI":"10.1016\/j.celrep.2022.111963","volume":"42","author":"JW Dean","year":"2023","unstructured":"Dean JW, Helm EY, Fu Z et al (2023) The aryl hydrocarbon receptor cell intrinsically promotes resident memory CD8\u2009+\u2009T cell differentiation and function. Cell Rep 42(1):111963. https:\/\/doi.org\/10.1016\/j.celrep.2022.111963","journal-title":"Cell Rep"},{"issue":"30","key":"12707_CR34","doi-asserted-by":"publisher","first-page":"12391","DOI":"10.1073\/pnas.1302856110","volume":"110","author":"JH Shin","year":"2013","unstructured":"Shin JH, Zhang L, Murillo-Sauca O et al (2013) Modulation of natural killer cell antitumor activity by the aryl hydrocarbon receptor. Proc Natl Acad Sci U S A 110(30):12391\u201312396. https:\/\/doi.org\/10.1073\/pnas.1302856110","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"12707_CR35","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/ni.2077","volume":"12","author":"MT Pallotta","year":"2011","unstructured":"Pallotta MT, Orabona C, Volpi C et al (2011) Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells. Nat Immunol 12(9):870\u2013878. https:\/\/doi.org\/10.1038\/ni.2077","journal-title":"Nat Immunol"},{"issue":"12","key":"12707_CR36","doi-asserted-by":"publisher","first-page":"e49756","DOI":"10.15252\/embr.201949756","volume":"21","author":"A Iacono","year":"2020","unstructured":"Iacono A, Pompa A, De Marchis F et al (2020) Class IA PI3Ks regulate subcellular and functional dynamics of IDO1. EMBO Rep 21(12):e49756. https:\/\/doi.org\/10.15252\/embr.201949756","journal-title":"EMBO Rep"},{"key":"12707_CR37","doi-asserted-by":"publisher","first-page":"101573","DOI":"10.1016\/j.arr.2022.101573","volume":"75","author":"A Salminen","year":"2022","unstructured":"Salminen A (2022) Role of indoleamine 2,3-dioxygenase 1 (IDO1) and kynurenine pathway in the regulation of the aging process. Ageing Res Rev 75:101573. https:\/\/doi.org\/10.1016\/j.arr.2022.101573","journal-title":"Ageing Res Rev"},{"issue":"4","key":"12707_CR38","doi-asserted-by":"publisher","first-page":"qiaf010","DOI":"10.1093\/jleuko\/qiaf010","volume":"117","author":"D Ocadlikova","year":"2025","unstructured":"Ocadlikova D, Fiordi B, Trabanelli S et al (2025) Noncanonical NF-\u03baB signaling in dendritic cells is required for ATP-driven indoleamine 2,3-dioxygenase 1 induction through P2Y11 receptor. J Leukoc Biol 117(4):qiaf010. https:\/\/doi.org\/10.1093\/jleuko\/qiaf010","journal-title":"J Leukoc Biol"},{"key":"12707_CR39","doi-asserted-by":"publisher","first-page":"104564","DOI":"10.1016\/j.biosystems.2021.104564","volume":"211","author":"K Trares","year":"2022","unstructured":"Trares K, Ackermann J, Koch I (2022) The canonical and non-canonical NF-\u03baB pathways and their crosstalk: A comparative study based on Petri nets. BioSystems 211:104564. https:\/\/doi.org\/10.1016\/j.biosystems.2021.104564","journal-title":"BioSystems"},{"issue":"1","key":"12707_CR40","doi-asserted-by":"publisher","first-page":"13867","DOI":"10.1038\/s41598-019-50454-z","volume":"9","author":"A Dhar","year":"2019","unstructured":"Dhar A, Chawla M, Chattopadhyay S et al (2019) Role of NF-kappaB2-p100 in regulatory T cell homeostasis and activation. Sci Rep 9(1):13867. https:\/\/doi.org\/10.1038\/s41598-019-50454-z","journal-title":"Sci Rep"},{"issue":"2","key":"12707_CR41","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00262-024-03925-w","volume":"74","author":"L Guangzhao","year":"2025","unstructured":"Guangzhao L, Xin W, Miaoqing W et al (2025) IDO1 inhibitor enhances the effectiveness of PD-1 blockade in microsatellite stable colorectal cancer by promoting macrophage pro-inflammatory phenotype polarization. Cancer Immunol Immunother 74(2):71. https:\/\/doi.org\/10.1007\/s00262-024-03925-w","journal-title":"Cancer Immunol Immunother"},{"issue":"4","key":"12707_CR42","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.jcmgh.2021.05.018","volume":"12","author":"X Zhang","year":"2021","unstructured":"Zhang X, Liu X, Zhou W et al (2021) Blockade of IDO-Kynurenine-AhR Axis Ameliorated Colitis-Associated Colon Cancer via Inhibiting Immune Tolerance. Cell Mol Gastroenterol Hepatol 12(4):1179\u20131199. https:\/\/doi.org\/10.1016\/j.jcmgh.2021.05.018","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"21","key":"12707_CR43","doi-asserted-by":"publisher","first-page":"7946","DOI":"10.3390\/ijms21217946","volume":"21","author":"K Walczak","year":"2020","unstructured":"Walczak K, Langner E, Makuch-Kocka A et al (2020) Effect of Tryptophan-Derived AhR Ligands, Kynurenine, Kynurenic Acid and FICZ, on Proliferation, Cell Cycle Regulation and Cell Death of Melanoma Cells-In Vitro Studies. Int J Mol Sci 21(21):7946. https:\/\/doi.org\/10.3390\/ijms21217946","journal-title":"Int J Mol Sci"},{"issue":"4","key":"12707_CR44","doi-asserted-by":"publisher","first-page":"e4065","DOI":"10.1002\/cbf.4065","volume":"42","author":"DS Nkandeu","year":"2024","unstructured":"Nkandeu DS, Joubert AM, Serem JC, Bipath P, Hlophe YN (2024) An exploratory study on the effect of kynurenine metabolites on sEnd-2 endothelioma cells. Cell Biochem Funct 42(4):e4065. https:\/\/doi.org\/10.1002\/cbf.4065","journal-title":"Cell Biochem Funct"},{"issue":"1","key":"12707_CR45","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s12967-025-06276-x","volume":"23","author":"Z Wu","year":"2025","unstructured":"Wu Z, Wang H, Zheng Z et al (2025) IDO1 inhibition enhances CLDN18.2-CAR-T cell therapy in gastrointestinal cancers by overcoming kynurenine-mediated metabolic suppression in the tumor microenvironment. J Transl Med 23(1):275. https:\/\/doi.org\/10.1186\/s12967-025-06276-x","journal-title":"J Transl Med"},{"key":"12707_CR46","doi-asserted-by":"publisher","first-page":"1346686","DOI":"10.3389\/fimmu.2024.1346686","volume":"15","author":"S Rossini","year":"2024","unstructured":"Rossini S, Ambrosino S, Volpi C et al (2024) Epacadostat stabilizes the apo-form of IDO1 and signals a pro-tumorigenic pathway in human ovarian cancer cells. Front Immunol 15:1346686. https:\/\/doi.org\/10.3389\/fimmu.2024.1346686","journal-title":"Front Immunol"},{"issue":"23","key":"12707_CR47","doi-asserted-by":"publisher","first-page":"9617","DOI":"10.1021\/acs.jmedchem.7b00974","volume":"60","author":"S Crosignani","year":"2017","unstructured":"Crosignani S, Bingham P, Bottemanne P et al (2017) Discovery of a Novel and Selective Indoleamine 2,3-Dioxygenase (IDO-1) Inhibitor 3-(5-Fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione (EOS200271\/PF-06840003) and Its Characterization as a Potential Clinical Candidate. J Med Chem 60(23):9617\u20139629. https:\/\/doi.org\/10.1021\/acs.jmedchem.7b00974","journal-title":"J Med Chem"},{"issue":"40","key":"12707_CR48","doi-asserted-by":"publisher","first-page":"e202209374","DOI":"10.1002\/anie.202209374","volume":"61","author":"C Davies","year":"2022","unstructured":"Davies C, D\u00f6tsch L, Ciulla MG et al (2022) Identification of a Novel Pseudo-Natural Product Type IV IDO1 Inhibitor Chemotype. Angew Chem Int Ed Engl 61(40):e202209374. https:\/\/doi.org\/10.1002\/anie.202209374","journal-title":"Angew Chem Int Ed Engl"},{"issue":"7","key":"12707_CR49","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1097\/CJI.0000000000000368","volume":"44","author":"N Kotecki","year":"2021","unstructured":"Kotecki N, Vuagnat P, O\u2019Neil BH et al (2021) A Phase I Study of an IDO-1 Inhibitor (LY3381916) as Monotherapy and in Combination With an Anti-PD-L1 Antibody (LY3300054) in Patients With Advanced Cancer. J Immunother 44(7):264\u2013275. https:\/\/doi.org\/10.1097\/CJI.0000000000000368","journal-title":"J Immunother"},{"issue":"1","key":"12707_CR50","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s40425-018-0351-9","volume":"6","author":"A Nayak-Kapoor","year":"2018","unstructured":"Nayak-Kapoor A, Hao Z, Sadek R et al (2018) Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors. J Immunother Cancer 6(1):61. https:\/\/doi.org\/10.1186\/s40425-018-0351-9","journal-title":"J Immunother Cancer"},{"issue":"5","key":"12707_CR51","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1021\/acsmedchemlett.6b00391","volume":"8","author":"EW Yue","year":"2017","unstructured":"Yue EW, Sparks R, Polam P et al (2017) INCB24360 (Epacadostat), a Highly Potent and Selective Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitor for Immuno-oncology. ACS Med Chem Lett 8(5):486\u2013491. https:\/\/doi.org\/10.1021\/acsmedchemlett.6b00391","journal-title":"ACS Med Chem Lett"},{"issue":"13","key":"12707_CR52","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1073\/pnas.1719190115","volume":"115","author":"MT Nelp","year":"2018","unstructured":"Nelp MT, Kates PA, Hunt JT et al (2018) Immune-modulating enzyme indoleamine 2,3-dioxygenase is effectively inhibited by targeting its apo-form. Proc Natl Acad Sci U S A 115(13):3249\u20133254. https:\/\/doi.org\/10.1073\/pnas.1719190115","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"12707_CR53","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.4161\/onci.21716","volume":"1","author":"R Metz","year":"2012","unstructured":"Metz R, Rust S, Duhadaway JB et al (2012) IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophan. Oncoimmunology 1(9):1460\u20131468. https:\/\/doi.org\/10.4161\/onci.21716","journal-title":"Oncoimmunology"},{"issue":"25","key":"12707_CR54","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.18632\/oncotarget.27646","volume":"11","author":"EL Brincks","year":"2020","unstructured":"Brincks EL, Adams J, Wang L et al (2020) Indoximod opposes the immunosuppressive effects mediated by IDO and TDO via modulation of AhR function and activation of mTORC1. Oncotarget 11(25):2438\u20132461. https:\/\/doi.org\/10.18632\/oncotarget.27646","journal-title":"Oncotarget"},{"issue":"1","key":"12707_CR55","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1001\/jamaoncol.2020.5572","volume":"7","author":"V Mariotti","year":"2021","unstructured":"Mariotti V, Han H, Ismail-Khan R et al (2021) Effect of Taxane Chemotherapy With or Without Indoximod in Metastatic Breast Cancer: A Randomized Clinical Trial. JAMA Oncol 7(1):61\u201369. https:\/\/doi.org\/10.1001\/jamaoncol.2020.5572","journal-title":"JAMA Oncol"},{"issue":"1","key":"12707_CR56","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40170-023-00307-1","volume":"11","author":"C Wu","year":"2023","unstructured":"Wu C, Spector SA, Theodoropoulos G et al (2023) Dual inhibition of IDO1\/TDO2 enhances anti-tumor immunity in platinum-resistant non-small cell lung cancer. Cancer Metab 11(1):7. https:\/\/doi.org\/10.1186\/s40170-023-00307-1","journal-title":"Cancer Metab"},{"issue":"15suppl","key":"12707_CR57","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1200\/JCO.2021.39.15_suppl.3101","volume":"39","author":"Y Cheng","year":"2021","unstructured":"Cheng Y, Liu Y, Xu J et al (2021) A phase I study of an IDO inhibitor (SHR9146) plus camrelizumab and in combination with\/without apatinib in patients with advanced solid tumors: Safety and efficacy analysis. J Clin Oncol 39(15suppl):3101\u20133101. https:\/\/doi.org\/10.1200\/JCO.2021.39.15_suppl.3101","journal-title":"J Clin Oncol"},{"key":"12707_CR58","unstructured":"Luye Pharma Group Ltd (2019) A non-randomized, open, dose escalation phase 1 clinical study evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of LPM3480226 tablets in patients with advanced solid tumors. ClinicalTrials.gov, NCT03844438. https:\/\/clinicaltrials.gov\/study\/NCT03844438. Accessed 5 May 2026"},{"issue":"2","key":"12707_CR59","doi-asserted-by":"publisher","first-page":"e000870","DOI":"10.1136\/jitc-2020-000870","volume":"8","author":"A Naing","year":"2020","unstructured":"Naing A, Eder JP, Piha-Paul SA et al (2020) Preclinical investigations and a first-in-human phase I trial of M4112, the first dual inhibitor of indoleamine 2,3-dioxygenase 1 and tryptophan 2,3-dioxygenase 2, in patients with advanced solid tumors. J Immunother Cancer 8(2):e000870. https:\/\/doi.org\/10.1136\/jitc-2020-000870","journal-title":"J Immunother Cancer"},{"key":"12707_CR60","doi-asserted-by":"publisher","first-page":"1191778","DOI":"10.3389\/fonc.2023.1191778","volume":"13","author":"M Xiao","year":"2023","unstructured":"Xiao M, Zhong K, Guo L et al (2023) Preclinical PK investigation of a novel IDO1\/TDO dual inhibitor\u2014SHR9146 in mouse plasma and tissues by LC-MS\/MS. Front Oncol 13:1191778. https:\/\/doi.org\/10.3389\/fonc.2023.1191778","journal-title":"Front Oncol"},{"key":"12707_CR61","doi-asserted-by":"publisher","first-page":"1680896","DOI":"10.3389\/fimmu.2025.1680896","volume":"16","author":"S Rossini","year":"2025","unstructured":"Rossini S, Ambrosino S, Volpi C et al (2025) Adverse pro-tumorigenic effects of IDO1 catalytic inhibitors mediated by the non-enzymatic function of IDO1 in tumor cells. Front Immunol 16:1680896. https:\/\/doi.org\/10.3389\/fimmu.2025.1680896","journal-title":"Front Immunol"},{"issue":"23","key":"12707_CR62","doi-asserted-by":"publisher","first-page":"15642","DOI":"10.1021\/acs.jmedchem.2c00771","volume":"65","author":"LR Bollu","year":"2022","unstructured":"Bollu LR, Bommi PV, Monsen PJ et al (2022) Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for Glioblastoma. J Med Chem 65(23):15642\u201315662. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c00771","journal-title":"J Med Chem"},{"issue":"2","key":"12707_CR63","doi-asserted-by":"publisher","first-page":"e000605","DOI":"10.1136\/jitc-2020-000605","volume":"8","author":"S Dey","year":"2020","unstructured":"Dey S, Sutanto-Ward E, Kopp KL et al (2020) Peptide vaccination directed against IDO1-expressing immune cells elicits CD8\u2009+\u2009and CD4\u2009+\u2009T-cell-mediated antitumor immunity and enhanced anti-PD1 responses. J Immunother Cancer 8(2):e000605. https:\/\/doi.org\/10.1136\/jitc-2020-000605","journal-title":"J Immunother Cancer"},{"issue":"3","key":"12707_CR64","doi-asserted-by":"publisher","first-page":"101707","DOI":"10.1016\/j.jbc.2022.101707","volume":"298","author":"MA Shandell","year":"2022","unstructured":"Shandell MA, Capatina AL, Lawrence SM, Brackenbury WJ, Lagos D (2022) Inhibition of the Na+\/K+-ATPase by cardiac glycosides suppresses expression of the IDO1 immune checkpoint in cancer cells by reducing STAT1 activation. J Biol Chem 298(3):101707. https:\/\/doi.org\/10.1016\/j.jbc.2022.101707","journal-title":"J Biol Chem"},{"issue":"10","key":"12707_CR65","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1158\/2767-9764.CRC-24-0272","volume":"4","author":"LW Kuo","year":"2024","unstructured":"Kuo LW, Crump LS, O\u2019Neill K et al (2024) Blocking Tryptophan Catabolism Reduces Triple-Negative Breast Cancer Invasive Capacity. Cancer Res Commun 4(10):2699\u20132713. https:\/\/doi.org\/10.1158\/2767-9764.CRC-24-0272","journal-title":"Cancer Res Commun"},{"issue":"22","key":"12707_CR66","doi-asserted-by":"publisher","first-page":"16236","DOI":"10.3390\/ijms242216236","volume":"24","author":"C Suvieri","year":"2023","unstructured":"Suvieri C, Marchis FD, Mandarano M et al (2023) Membrane Localization and Phosphorylation of Indoleamine 2,3-Dioxygenase 2 (IDO2) in A549 Human Lung Adenocarcinoma Cells: First Steps in Exploring Its Signaling Function. Int J Mol Sci 24(22):16236. https:\/\/doi.org\/10.3390\/ijms242216236","journal-title":"Int J Mol Sci"},{"issue":"3","key":"12707_CR67","doi-asserted-by":"publisher","first-page":"571","DOI":"10.4049\/jimmunol.2100705","volume":"208","author":"LMF Merlo","year":"2022","unstructured":"Merlo LMF, Peng W, DuHadaway JB et al (2022) The Immunomodulatory Enzyme IDO2 Mediates Autoimmune Arthritis through a Nonenzymatic Mechanism. J Immunol 208(3):571\u2013581. https:\/\/doi.org\/10.4049\/jimmunol.2100705","journal-title":"J Immunol"},{"issue":"3","key":"12707_CR68","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.4049\/jimmunol.1300720","volume":"192","author":"S Trabanelli","year":"2014","unstructured":"Trabanelli S, O\u010dadl\u00edkov\u00e1 D, Ciciarello M et al (2014) The SOCS3-independent expression of IDO2 supports the homeostatic generation of T regulatory cells by human dendritic cells. J Immunol 192(3):1231\u20131240. https:\/\/doi.org\/10.4049\/jimmunol.1300720","journal-title":"J Immunol"},{"key":"12707_CR69","doi-asserted-by":"publisher","first-page":"117864692211384","DOI":"10.1177\/11786469221138456","volume":"15","author":"S Yoshioka","year":"2022","unstructured":"Yoshioka S, Ikeda T, Fukuchi S et al (2022) Identification and Characterization of a Novel Dual Inhibitor of Indoleamine 2,3-dioxygenase 1 and Tryptophan 2,3-dioxygenase. Int J Tryptophan Res 15:11786469221138456. https:\/\/doi.org\/10.1177\/11786469221138456","journal-title":"Int J Tryptophan Res"},{"key":"12707_CR70","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.3389\/fimmu.2020.01861","volume":"11","author":"LMF Merlo","year":"2020","unstructured":"Merlo LMF, DuHadaway JB, Montgomery JD et al (2020) Differential Roles of IDO1 and IDO2 in T and B Cell Inflammatory Immune Responses. Front Immunol 11:1861. https:\/\/doi.org\/10.3389\/fimmu.2020.01861","journal-title":"Front Immunol"},{"issue":"30","key":"12707_CR71","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1021\/acs.biochem.0c00179","volume":"59","author":"J Geng","year":"2020","unstructured":"Geng J, Weitz AC, Dornevil K, Hendrich MP, Liu A (2020) Kinetic and Spectroscopic Characterization of the Catalytic Ternary Complex of Tryptophan 2,3-Dioxygenase. Biochemistry 59(30):2813\u20132822. https:\/\/doi.org\/10.1021\/acs.biochem.0c00179","journal-title":"Biochemistry"},{"issue":"23","key":"12707_CR72","doi-asserted-by":"publisher","first-page":"e2022447118","DOI":"10.1073\/pnas.2022447118","volume":"118","author":"S Klaessens","year":"2021","unstructured":"Klaessens S, Stroobant V, Hoffmann D et al (2021) Tryptophanemia is controlled by a tryptophan-sensing mechanism ubiquitinating tryptophan 2,3-dioxygenase. Proc Natl Acad Sci U S A 118(23):e2022447118. https:\/\/doi.org\/10.1073\/pnas.2022447118","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"12707_CR73","doi-asserted-by":"publisher","first-page":"35169","DOI":"10.1038\/srep35169","volume":"6","author":"A Lewis-Ballester","year":"2016","unstructured":"Lewis-Ballester A, Forouhar F, Kim SM et al (2016) Molecular basis for catalysis and substrate-mediated cellular stabilization of human tryptophan 2,3-dioxygenase. Sci Rep 6(1):35169. https:\/\/doi.org\/10.1038\/srep35169","journal-title":"Sci Rep"},{"issue":"50","key":"12707_CR74","doi-asserted-by":"publisher","first-page":"15690","DOI":"10.1021\/ja076186k","volume":"129","author":"D Batabyal","year":"2007","unstructured":"Batabyal D, Yeh SR (2007) Human Tryptophan Dioxygenase: A Comparison to Indoleamine 2,3-Dioxygenase. J Am Chem Soc 129(50):15690\u201315701. https:\/\/doi.org\/10.1021\/ja076186k","journal-title":"J Am Chem Soc"},{"issue":"2","key":"12707_CR75","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1042\/BJ20120416","volume":"446","author":"Q Han","year":"2012","unstructured":"Han Q, Robinson H, Li J (2012) Biochemical identification and crystal structure of kynurenine formamidase from Drosophila melanogaster. Biochem J 446(2):253\u2013260. https:\/\/doi.org\/10.1042\/BJ20120416","journal-title":"Biochem J"},{"key":"12707_CR76","doi-asserted-by":"publisher","first-page":"590532","DOI":"10.3389\/fimmu.2021.590532","volume":"12","author":"SR Mohapatra","year":"2021","unstructured":"Mohapatra SR, Sadik A, Sharma S et al (2021) Hypoxia Routes Tryptophan Homeostasis Towards Increased Tryptamine Production. Front Immunol 12:590532. https:\/\/doi.org\/10.3389\/fimmu.2021.590532","journal-title":"Front Immunol"},{"issue":"4","key":"12707_CR77","doi-asserted-by":"publisher","first-page":"e59749","DOI":"10.1371\/journal.pone.0059749","volume":"8","author":"W Wu","year":"2013","unstructured":"Wu W, Nicolazzo JA, Wen L et al (2013) Expression of Tryptophan 2,3-Dioxygenase and Production of Kynurenine Pathway Metabolites in Triple Transgenic Mice and Human Alzheimer\u2019s Disease Brain. PLoS ONE 8(4):e59749. https:\/\/doi.org\/10.1371\/journal.pone.0059749","journal-title":"PLoS ONE"},{"issue":"4","key":"12707_CR78","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/iub.1144","volume":"65","author":"KM Roberts","year":"2013","unstructured":"Roberts KM, Fitzpatrick PF (2013) Mechanisms of tryptophan and tyrosine hydroxylase. IUBMB Life 65(4):350\u2013357. https:\/\/doi.org\/10.1002\/iub.1144","journal-title":"IUBMB Life"},{"key":"12707_CR79","doi-asserted-by":"publisher","first-page":"109975","DOI":"10.1016\/j.enzmictec.2021.109975","volume":"154","author":"MA Vargas","year":"2022","unstructured":"Vargas MA, Deive FJ, \u00c1lvarez MS et al (2022) Effect of process parameters and surfactant additives on the obtained activity of recombinant tryptophan hydroxylase (TPH1) for enzymatic synthesis of 5-hydroxytryptophan (5-HTP). Enzyme Microb Technol 154:109975. https:\/\/doi.org\/10.1016\/j.enzmictec.2021.109975","journal-title":"Enzyme Microb Technol"},{"issue":"10","key":"12707_CR80","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.3390\/biomedicines10102418","volume":"10","author":"F Reverchon","year":"2022","unstructured":"Reverchon F, Guillard C, Mollet L et al (2022) T Lymphocyte Serotonin 5-HT7 Receptor Is Dysregulated in Natalizumab-Treated Multiple Sclerosis Patients. Biomedicines 10(10):2418. https:\/\/doi.org\/10.3390\/biomedicines10102418","journal-title":"Biomedicines"},{"issue":"1","key":"12707_CR81","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00018-024-05570-z","volume":"82","author":"FS Bahr","year":"2025","unstructured":"Bahr FS, M\u00fcller FE, Kasten M et al (2025) Serotonin receptor 5-HT7 modulates inflammatory-associated functions of macrophages. Cell Mol Life Sci 82(1):51. https:\/\/doi.org\/10.1007\/s00018-024-05570-z","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"12707_CR82","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00441-021-03556-y","volume":"388","author":"WL Zhang","year":"2022","unstructured":"Zhang WL, Zhang ZL, Peng J et al (2022) Expression of arylalkylamine n-acetyltransferase (AANAT) and acetylserotonin o-methyltransferase (ASMT) in the corpus luteum of pregnant sows and synthesis of melatonin in luteal cells. Cell Tissue Res 388(1):167\u2013179. https:\/\/doi.org\/10.1007\/s00441-021-03556-y","journal-title":"Cell Tissue Res"},{"issue":"1","key":"12707_CR83","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41420-023-01568-x","volume":"9","author":"M Zuo","year":"2023","unstructured":"Zuo M, Fang J, Huang P et al (2023) IL4I1-catalyzed tryptophan metabolites mediate the anti-inflammatory function of cytokine-primed human muscle stem cells. Cell Death Discov 9(1):269. https:\/\/doi.org\/10.1038\/s41420-023-01568-x","journal-title":"Cell Death Discov"},{"issue":"4","key":"12707_CR84","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.3390\/ijms24043163","volume":"24","author":"JM Luo","year":"2023","unstructured":"Luo JM, Zhang TT, He YY, Luo HN, Hong YQ, Yang ZM (2023) Human Chorionic Gonadotropin-Stimulated Interleukin-4-Induced-1 (IL4I1) Promotes Human Decidualization via Aryl Hydrocarbon Receptor. Int J Mol Sci 24(4):3163. https:\/\/doi.org\/10.3390\/ijms24043163","journal-title":"Int J Mol Sci"},{"key":"12707_CR85","doi-asserted-by":"publisher","first-page":"114439","DOI":"10.1016\/j.intimp.2025.114439","volume":"152","author":"Q Liu","year":"2025","unstructured":"Liu Q, Deng G, Jiang X et al (2025) Macrophage-mediated activation of the IL4I1\/AhR axis is a key player in allergic rhinitis. Int Immunopharmacol 152:114439. https:\/\/doi.org\/10.1016\/j.intimp.2025.114439","journal-title":"Int Immunopharmacol"},{"key":"12707_CR86","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1186\/s12967-024-05934-w","volume":"22","author":"G Chen","year":"2024","unstructured":"Chen G, Qi H, Jiang L et al (2024) Integrating single-cell RNA-Seq and machine learning to dissect tryptophan metabolism in ulcerative colitis. J Transl Med 22:1121. https:\/\/doi.org\/10.1186\/s12967-024-05934-w","journal-title":"J Transl Med"},{"issue":"9","key":"12707_CR87","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1038\/s42255-024-01115-7","volume":"6","author":"SR Sukka","year":"2024","unstructured":"Sukka SR, Ampomah PB, Darville LNF et al (2024) Efferocytosis drives a tryptophan metabolism pathway in macrophages to promote tissue resolution. Nat Metab 6(9):1736\u20131755. https:\/\/doi.org\/10.1038\/s42255-024-01115-7","journal-title":"Nat Metab"},{"issue":"2","key":"12707_CR88","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.immuni.2013.08.003","volume":"39","author":"T Zelante","year":"2013","unstructured":"Zelante T, Iannitti RG, Cunha C et al (2013) Tryptophan Catabolites from Microbiota Engage Aryl Hydrocarbon Receptor and Balance Mucosal Reactivity via Interleukin-22. Immunity 39(2):372\u2013385. https:\/\/doi.org\/10.1016\/j.immuni.2013.08.003","journal-title":"Immunity"},{"issue":"6","key":"12707_CR89","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1053\/j.gastro.2022.01.008","volume":"162","author":"M Priyadarshini","year":"2022","unstructured":"Priyadarshini M, Navarro G, Reiman DJ et al (2022) Gestational Insulin Resistance Is Mediated by the Gut Microbiome\u2013Indoleamine 2,3-Dioxygenase Axis. Gastroenterology 162(6):1675\u20131689e11. https:\/\/doi.org\/10.1053\/j.gastro.2022.01.008","journal-title":"Gastroenterology"},{"issue":"11","key":"12707_CR90","doi-asserted-by":"publisher","first-page":"108279","DOI":"10.1016\/j.isci.2023.108279","volume":"26","author":"Y Xia","year":"2023","unstructured":"Xia Y, Liu C, Li R et al (2023) Lactobacillus-derived indole-3-lactic acid ameliorates colitis in cesarean-born offspring via activation of aryl hydrocarbon receptor. iScience 26(11):108279. https:\/\/doi.org\/10.1016\/j.isci.2023.108279","journal-title":"iScience"},{"key":"12707_CR91","doi-asserted-by":"publisher","first-page":"1154346","DOI":"10.3389\/fcimb.2023.1154346","volume":"13","author":"T Pan","year":"2023","unstructured":"Pan T, Pei Z, Fang Z et al (2023) Uncovering the specificity and predictability of tryptophan metabolism in lactic acid bacteria with genomics and metabolomics. Front Cell Infect Microbiol 13:1154346. https:\/\/doi.org\/10.3389\/fcimb.2023.1154346","journal-title":"Front Cell Infect Microbiol"},{"issue":"8","key":"12707_CR92","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/s41591-018-0060-4","volume":"24","author":"L Laurans","year":"2018","unstructured":"Laurans L, Venteclef N, Haddad Y et al (2018) Genetic deficiency of indoleamine 2,3-dioxygenase promotes gut microbiota-mediated metabolic health. Nat Med 24(8):1113\u20131120. https:\/\/doi.org\/10.1038\/s41591-018-0060-4","journal-title":"Nat Med"},{"issue":"7","key":"12707_CR93","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1016\/j.cell.2024.02.022","volume":"187","author":"D Jia","year":"2024","unstructured":"Jia D, Wang Q, Qi Y et al (2024) Microbial metabolite enhances immunotherapy efficacy by modulating T cell stemness in pan-cancer. Cell 187(7):1651\u20131665e21. https:\/\/doi.org\/10.1016\/j.cell.2024.02.022","journal-title":"Cell"},{"issue":"13","key":"12707_CR94","doi-asserted-by":"publisher","first-page":"3958","DOI":"10.1021\/acs.jafc.1c04145","volume":"70","author":"JE Koper","year":"2022","unstructured":"Koper JE, Troise AD, Loonen LM et al (2022) Tryptophan Supplementation Increases the Production of Microbial-Derived AhR Agonists in an In Vitro Simulator of Intestinal Microbial Ecosystem. J Agric Food Chem 70(13):3958\u20133968. https:\/\/doi.org\/10.1021\/acs.jafc.1c04145","journal-title":"J Agric Food Chem"},{"issue":"1","key":"12707_CR95","doi-asserted-by":"publisher","first-page":"5753","DOI":"10.1038\/s41467-023-41536-8","volume":"14","author":"G Renga","year":"2023","unstructured":"Renga G, D\u2019Onofrio F, Pariano M et al (2023) Bridging of host-microbiota tryptophan partitioning by the serotonin pathway in fungal pneumonia. Nat Commun 14(1):5753. https:\/\/doi.org\/10.1038\/s41467-023-41536-8","journal-title":"Nat Commun"},{"issue":"11","key":"12707_CR96","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1158\/1078-0432.CCR-24-0439","volume":"31","author":"JJ Luke","year":"2025","unstructured":"Luke JJ, Gelmon K, Siu LL et al (2025) Phase 1\/2 Study of the Indoleamine 2,3-Dioxygenase 1 Inhibitor Linrodostat Mesylate Combined with Nivolumab or Nivolumab and Ipilimumab in Advanced Solid Tumors or Hematologic Malignancies. Clin Cancer Res 31(11):2134\u20132144. https:\/\/doi.org\/10.1158\/1078-0432.CCR-24-0439","journal-title":"Clin Cancer Res"},{"key":"12707_CR97","doi-asserted-by":"publisher","first-page":"1134551","DOI":"10.3389\/fimmu.2023.1134551","volume":"14","author":"E Panfili","year":"2023","unstructured":"Panfili E, Mondanelli G, Orabona C et al (2023) The catalytic inhibitor epacadostat can affect the non-enzymatic function of IDO1. Front Immunol 14:1134551. https:\/\/doi.org\/10.3389\/fimmu.2023.1134551","journal-title":"Front Immunol"},{"issue":"Suppl 1","key":"12707_CR98","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1186\/s12885-023-11203-8","volume":"23","author":"T Tokito","year":"2024","unstructured":"Tokito T, Kolesnik O, S\u00f8rensen J et al (2024) Epacadostat plus pembrolizumab versus placebo plus pembrolizumab as first-line treatment for metastatic non-small cell lung cancer with high levels of programmed death-ligand 1: a randomized, double-blind phase 2 study. BMC Cancer 23(Suppl 1):1251. https:\/\/doi.org\/10.1186\/s12885-023-11203-8","journal-title":"BMC Cancer"},{"issue":"4","key":"12707_CR99","doi-asserted-by":"publisher","first-page":"4961","DOI":"10.1021\/acs.jmedchem.5c00026","volume":"68","author":"PJ Monsen","year":"2025","unstructured":"Monsen PJ, Bommi PV, Grigorescu AA et al (2025) Rational Design and Optimization of a Potent IDO1 Proteolysis Targeting Chimera (PROTAC). J Med Chem 68(4):4961\u20134987. https:\/\/doi.org\/10.1021\/acs.jmedchem.5c00026","journal-title":"J Med Chem"},{"issue":"3","key":"12707_CR100","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1158\/1078-0432.CCR-24-0037","volume":"31","author":"EV Mastrolonardo","year":"2025","unstructured":"Mastrolonardo EV, Nunes KL, Llerena P et al (2025) Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma. Clin Cancer Res 31(3):515\u2013528. https:\/\/doi.org\/10.1158\/1078-0432.CCR-24-0037","journal-title":"Clin Cancer Res"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12707-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12707-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12707-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T07:33:19Z","timestamp":1789198399000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12707-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,12]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12707"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12707-9","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,12]]},"assertion":[{"value":"8 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. This article is a review of previously published studies and does not involve human participants, animals, or identifiable personal data. Therefore, ethical approval was not required.","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to Publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1567"}}